UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Zero based budgeting is ideal for those looking to take control of their finances. Discover who should consider this method for budgeting success.
25,948 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
As millions of Baby Boomers retire, a fundamental shift is underway for markets and investment strategies. This story...
A new Allianz study shows Gen X is the cohort most worried about taxes in retirement, with rising fears about how tax...
Costco just posted strong Q2 FY26 results, fueling a bullish one-year outlook. This article breaks down the data, gro...
HOA governance risk is reshaping due diligence for homebuyers. This report explains what real estate agents should sc...
Retail investors face shrinking net returns as private equity fees compress gains. A timely look at Jeff Hook’s blunt...
The Saver’s Match will begin in 2027, offering eligible workers a 50% government match up to $1,000 annually. Kipling...
Bitcoin tumbled to the low $71,000s on June 1, 2026, as geopolitical tensions sparked a wave of liquidations across c...
Redwire’s backlog and contract wins are lifting the stock, but the company remains unprofitable. This report weighs t...
A top broker unleashes a monster target on Micron, triggering questions about whether wall street just monster pricin...
Analysts rolled out a fresh slate of calls on Block, Cognizant, First Solar and others as markets navigate midweek vo...
Roughly 1 in 10 Medicare Advantage enrollees will lose their current plan for 2026 as insurers retreat from markets. ...